NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/16/2024
Back to search
Official data from USPTO
INSIGNIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
04/16/2024
Trademark type
Combined
Nice classes
1, 5, 10, 42
Filing date
08/31/2020
Registration date
04/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/16/2024
Last transaction
04/16/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
99
Owner location
Eveleigh, AU
Examiner
BAKER, JORDAN A
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "INSIGNIA" in stylized form.
Holders and representatives
Holders
SpeeDx Pty Ltd
Representatives
Joi A. White Carr & Ferrell LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industrysciencephotographyagriculturehorticulture and forestryexcept fungicidesherbicidesinsecticidesparasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acidsinorganic acids for industrial purposes; DNA and RNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 5
Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; enzymes for pharmaceuticalveterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 10
Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing apparatus and instruments for medical purposesfor use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing kits containing diagnostic testing apparatus for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; point of care medical devices for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; screening kits consisting of medical screening and testing apparatus for the diagnosis of diseasedetection and/or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; all of the foregoing excluding heart pacemakers and stethoscopes and orthopedic implants and excluding apparatusinstruments and devices for use with orthopedic surgery and excluding surgical staplers and accessories therefor
Class 42
Scientific and technological services and research and design relating theretoin the field of DNA analysis services for scientific research analysisscientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicalDNARNAproteinpolynucleic acid and molecular analysis and evaluation services for scientific purposes and medical research purposes; DNA and RNA and polynucleic acid and protein sequencinganalysis and evaluation servicesfor scientific purposes and medical research purposes; genome sequencing services and the analysis and evaluation of data resulting therefromfor scientific purposes and medical research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsrelating to the results of scientific and medical experiments and testsrelating to the analysis and evaluation of scientific and medical datarelating to data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of medical research and genetics; custom design and development of biochemical assays
Publications
History of USPTO decisions and trademark events.
54 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/16/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
03/11/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
02/22/2024
APET
ASSIGNED TO PETITION STAFF
02/20/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/23/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2024
PUBO
PUBLISHED FOR OPPOSITION
01/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/19/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/19/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/19/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/19/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/12/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/21/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/21/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/21/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/18/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/31/2023
GNFR
FINAL REFUSAL E-MAILED
05/31/2023
CNFR
FINAL REFUSAL WRITTEN
05/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2023
GNRT
NON-FINAL ACTION E-MAILED
02/14/2023
CNRT
NON-FINAL ACTION WRITTEN
02/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/27/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/22/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/20/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/22/2021
GNSL
LETTER OF SUSPENSION E-MAILED
07/22/2021
CNSL
SUSPENSION LETTER WRITTEN
07/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2021
ALIE
ASSIGNED TO LIE
07/21/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2021
GNRT
NON-FINAL ACTION E-MAILED
01/05/2021
CNRT
NON-FINAL ACTION WRITTEN
01/05/2021
DOCK
ASSIGNED TO EXAMINER
01/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2020
NWAP
NEW APPLICATION ENTERED
09/03/2020
Continuous trademark protection
Get notified about every new filing that threatens INSIGNIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.